Patent · US Active

Method of treating tumors

US9115169B2 · kind B2 · utility

0Cited by

5References

6Claims

0Family size

Assignee

LYTIX BIOPHARMA AS · NO

Inventors

John Sigurd Svendsen · Tromsø, NO
Bengt Erik Haug · Kleppestø, NO
Istvan Marko · Louvain-la-Neuve, BE
Øystein Rekdal · Tromsø, NO
Merete Linchausen Skar · Tromsø, NO
Wenche Stensen · Norheim, NO
Morten Bøhmer Strøm · Tromsø, NO

Key dates

Filing date	Sep 22, 2011
Grant date	Aug 25, 2015
Priority date	—
Expiry date	Dec 21, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a method of treating tumors by adminstering to a human or animal patient an effective amount of a molecule of 2 to 4 amino acids or equivalent subunits in length, which incorporates a bulky and lipophilic group comprising at least 13 non-hydrogen atoms and containing no more than 2 polar functional groups, in which the bulky and lipophilic group incorporates one or more closed rings of 5 or more non-hydrogen atoms, and in which the molecule further has at least two more cationic than anionic moieties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.